Filing Details

Accession Number:
0001553878-18-000022
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-14 19:40:11
Reporting Period:
2018-03-13
Accepted Time:
2018-03-14 19:40:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1381994 A Dennis Ausiello 300 Third Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-13 2,117 $63.86 2,117 No 4 M Direct
Common Stock Acquisiton 2018-03-13 15,000 $59.25 17,117 No 4 M Direct
Common Stock Disposition 2018-03-13 17,117 $150.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-03-13 15,000 $0.00 15,000 $59.25
Common Stock Stock Option (right to buy) Disposition 2018-03-13 2,117 $0.00 2,117 $63.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-06-05 2024-06-04 No 4 M Direct
0 2014-03-31 2024-01-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,500 Indirect by Trust
Footnotes
  1. The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2017.
  2. The shares of ALNY common stock are held in a trust, of which the reporting person's spouse is the trustee.